Covalis Capital’s Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 PNTM.WS Stock Holding History

Covalis Capital’s Portfolio PNTM.WS Stock Details PNTM.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-233,332	Closed	-$1.04M	–	91
2022 Q1	$1.04M	Hold	233,332	–	–	0.28%	50
2021 Q4	$1.06M	Hold	233,332	–	–	0.39%	34
2021 Q3	$958K	Hold	233,332	–	–	0.22%	56
2021 Q2	$1.05M	Buy	+233,332	New	+$193K	0.34%	43

Other funds holding PNTM.WS

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Covalis Capital's PNTM.WS Position: Q2 2022 in Review

Covalis Capital sold out of Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (PNTM.WS) in Q2 2022, closing a stake of 233,332 shares — an estimated $1.04M sold.

Covalis Capital first reported a position in PNTM.WS in Q2 2021 and held it in 4 quarters. The position peaked at $1.06M in Q4 2021. 70 funds tracked by Wall St. Rank hold PNTM.WS as of Q2 2022.

Covalis Capital reported no remaining Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
Covalis Capital sold 233,332 Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2022, an estimated $1.04M.
Covalis Capital first reported a position in Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2021 and held it in 4 quarters.
Covalis Capital's Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $1.06M in Q4 2021.
70 funds tracked by Wall St. Rank held Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2022.

Based on Covalis Capital's 13F filing for Q2 2022, filed 15 Aug 2022.